Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats. - Wikidata - awgldk - TriplyDB

Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats.

Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats.

http://www.wikidata.org/entity/Q38466904

about

Pharmacokinetics of enzalutamide, an anti-prostate cancer drug, in rats.(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.Efficacy of (S)-Lacosamide in preclinical models of cephalic pain.Acute or chronic use of lacosamide does not alter its distribution between serum and cerebrospinal fluid.Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons.Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate.Distribution of lacosamide in the rat brain assessed by in vitro slice technique.CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat.

P2860

Q34475712-371A6D7E-4DF1-4931-9228-5865138C9EF4 Q37074848-F7E42F4B-E2AA-4A34-A392-3D0DB7CFDD54 Q37451570-77D11FCF-62A3-4D03-906B-1ED9FAA7B829 Q40651545-C1606758-50E9-4C2B-B3DC-6181B29DEEBA Q45363773-508AF3AA-CBBA-46E0-BA56-AE4191A6BA77 Q47224710-4A8527CB-C3A3-40F5-BFF1-43413709228A Q47668140-45386F48-0059-4808-AE62-EC376DCBB23A Q47976317-D6CA0A0C-21E0-4B79-B640-6AEB678627E9 Q48205863-DA2267C6-1B24-4A56-A9CB-0AD3949E2B28 Q49053027-CC804793-78C8-4F08-8CD8-F591E4D154E8

P2860

Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats.

http://www.wikidata.org/entity/Q38466904

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Pharmacokinetics, brain distri ...... eptic drug lacosamide in rats.

@en

type

label

Pharmacokinetics, brain distri ...... eptic drug lacosamide in rats.

@en

prefLabel

Pharmacokinetics, brain distri ...... eptic drug lacosamide in rats.

@en

P1433

Q38466904-0D1F0A02-9A5A-4D12-87EC-C57DCA8AF08F

P1476

Q38466904-B09643D4-0CAD-4E6C-B040-74B6B6DB475D

P2093

Q38466904-106C6846-10A9-4179-8655-88D1C650F49C

Q38466904-4206AA13-BA47-4F1A-A865-85F0E720316F

Q38466904-762FE27B-32D2-48AC-9A02-DCB0F7312808

Q38466904-B47AD785-9C69-4B0D-86F3-64D098E02DBB

Q38466904-D0CD979A-65BF-44EC-B533-481B28BF3AA2

P2860

Q38466904-4E0F869C-E2CB-4D2F-B150-6C5116404A8F

Q38466904-54D31BC3-9750-4961-A630-394E09E1862C

Q38466904-5C1A846B-D302-4FAD-90EC-643CF3D020F6

Q38466904-70EF7E35-B6E5-4CD6-99E1-0C6F6C14C477

Q38466904-8D0A6985-5BA5-4084-BFAD-B91DD0CA8CF0

Q38466904-8D699BAE-3B3D-4DDA-BF92-D4783E1A58F9

Q38466904-B568C1FA-7718-48DA-9DA5-3D25B1C841BF

Q38466904-D41B509E-210C-43E6-82EC-C3E005818AF7

Q38466904-FE713B9F-3C05-4805-9503-34B0407B1F18

P2888

Q38466904-3B544B41-2F1E-4E25-8AB3-0FBADF1B505B

P304

Q38466904-49994195-9335-4ECD-BFC6-CAED348D3C89

P31

Q38466904-75E63EA6-2F7B-4EAE-9747-912D518B23E9

P356

Q38466904-73F20ADA-CADC-4573-984A-6E2BD909FFFE

P433

Q38466904-E855BDD9-F13E-43F6-8364-46C08734076F

P478

Q38466904-3BA53536-9FA5-4AE6-B161-E4044563DE1B

P577

Q38466904-97812DA6-29D7-4D24-BFDE-A383298E443C

P6179

Q38466904-76866314-3B6D-4F4E-A959-0622C1B0384C

P698

Q38466904-764E0699-5295-44CB-9980-CD03B2FF90F5

P356

S12272-011-1208-7

P1433

Archives of Pharmacal Research

P1476

Pharmacokinetics, brain distri ...... eptic drug lacosamide in rats.

@en

P2093

Dong-Jin Ha

http://www.w3.org/2001/XMLSchema#string

Hongsik Moon

http://www.w3.org/2001/XMLSchema#string

Myoungki Baek

http://www.w3.org/2001/XMLSchema#string

Soo-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Tae-Sung Koo

http://www.w3.org/2001/XMLSchema#string

P2860

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.

Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.

Seeking a mechanism of action for the novel anticonvulsant lacosamide.

Lacosamide: a review of preclinical properties.

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

The clinical impact of new antiepileptic drugs after a decade of use in epilepsy.

Lacosamide: in partial-onset seizures.

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.

P2888

s12272-011-1208-7

P304

2059-2064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-011-1208-7

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006246914

http://www.w3.org/2001/XMLSchema#string

P698

22210031

http://www.w3.org/2001/XMLSchema#string